Article无锡医保诈骗案相关问题与案例解析2024年10月8日,国家医保局官方发布重磅消息,无锡某医院涉嫌违法违规使用医保基金2228.4万元,ChinaInsuranceAnJie Broad Law Firm
Article新法速评 — 2022年《药品召回管理办法》要点解读2022年10月26日,国家药监局发布了刚刚正式通过的新《药品召回管理办法》(下称新《办法》)。我国现行《药品召回管理办法》于2007年12月10日公布ChinaFood, Drugs, Healthcare, Life SciencesHan Kun Law Offices
Article"互联网+医疗"领域的主要业务类型及其关注热点(续)Q&A如前期所述,互联网健康咨询的服务范围主要包括线上健康评估、健康指导、健康宣教、就诊指导、心理疏导等非诊疗行为的"信息服务业务";&#ChinaFood, Drugs, Healthcare, Life SciencesAnJie Broad Law Firm
Article中国企业出海法律合规系列 ——欧盟首次启动《国际采购工具》对中国市场进行调查2024年4月24日,欧盟委员会(European Commission,"欧委会")公告首次适用《国际采购工具》(International Procurement Instrument,"IPI法案")[1]启动调查...ChinaCorporate/Commercial LawAnJie Broad Law Firm
ArticleHan Kun • Opinion | Implementation And Regulation Of DCT (Decentralized Clinical Trials) In ChinaThe concept of "patient-centered" has become the core guiding ideology of current drug development. "Patient-centered" drug development refers to the process...ChinaFood, Drugs, Healthcare, Life SciencesHan Kun Law Offices
Article医疗机构投资并购之法律尽职调查实务分析在国家医疗体制改革、支持社会办医及医疗大健康产业飞速发展的背景下,医疗机构并购领域已成为传统医疗集团和各路产业资本(地产商、ChinaFood, Drugs, Healthcare, Life SciencesDeHeng Law Offices
ArticleChina On The Move: Lessons From China's 2023 National Negotiation Of Drug PricesIn December 2023, China's National Healthcare Security Administration (NHSA) published the 2023 National Reimbursement Drug List (2023 NRDL), implementing a comparable level of pricing discounts...ChinaFood, Drugs, Healthcare, Life SciencesGreenberg Traurig
Article开启直播电商合规新纪元 |《直播电商监督管理办法》重点解读(下)日前,市场监管总局、国家网信办联合发布...ChinaMedia, Telecoms, IT, EntertainmentFangda Partners
Article违反疫情防控规定致他人损害行为之民事侵权责任探析2月2日,福建省晋江市英林镇通报一起感染新冠肺炎病例,男子张某某武汉返乡却谎称从菲律宾回来,未按规定进行居家隔离,还多次参加宴席&#ChinaLitigation, Mediation & ArbitrationDeHeng Law Offices
ArticleHighlights On The New Drug Recall Regulation Of 2022On October 26, 2022, the National Medical Products Administration ("NMPA") issued the newly revised Measures for the Administration of Drug Recalls ("the 2022 Measures") that has just been formally adopted.ChinaFood, Drugs, Healthcare, Life SciencesHan Kun Law Offices
Article2024 Data Analytics: China Life Sciences NewCo & Licensing TermsLicense-in/out transactions have become a key strategic approach for innovative drug and medical device (including medical aesthetics) companies to expedite the research and development of the products and expand market presence.ChinaFood, Drugs, Healthcare, Life SciencesHan Kun Law Offices
Article干细胞与基因治疗领域扩大开放新政及CAR-T地方监管新规初探近年来细胞和基因治疗(CGT)领域随着相关科学理论、技术手段和临床医疗实践的不断演进而蓬勃发展。ChinaFood, Drugs, Healthcare, Life SciencesAnJie Broad Law Firm
Article汉坤 • 观点 | LDT试点新规解读近年来,我国不断探索对LDT的监管。随着一系列新规的出台,有众多优秀的跨国及本土公司均参与到该领域的研究中...ChinaFood, Drugs, Healthcare, Life SciencesHan Kun Law Offices
ArticleHan Kun • Opinion | Analysis Of Key Points Of License-In/out Contract Disputes In The Life Sciences Industry (1): Joint Steering Committee, Reasonable Commercial Efforts, Confidentiality ObligationsLicense-in/out is a common transaction model in the pharmaceutical field in recent years, that is, the licensor licensees the relevant R&D technology and patents...ChinaFood, Drugs, Healthcare, Life SciencesHan Kun Law Offices
Article生物创新药的专利布局与保护——以曲妥珠单抗为例生物医药产业的发展高度依赖知识产权保护。本文以曲妥珠单抗(赫赛汀)为例,深入分析了创新药企业如何通过系统性专利布局,从时间和技术ChinaIntellectual PropertyJincheng Tongda & Neal
Article汉坤 • 观点 | 《药品管理法实施条例》(修订草案)重点快评2022年5月9日,国家药监局发布《药品管理法实施条例(修订草案征求意见稿)》(简称"《征求意见稿》"),向社会公开征求意见,征求意见反馈截止ChinaFood, Drugs, Healthcare, Life SciencesHan Kun Law Offices
Article"互联网+医疗"领域的主要业务类型及其关注热点"互联网+医疗"指互联网在线医疗服务,是互联网在医疗行业的新应用。近年来"互联网+医疗"在中国发展迅猛。ChinaMedia, Telecoms, IT, EntertainmentAnJie Broad Law Firm
Article新型冠状病毒肺炎应适用不可抗力制度?抑或情势变更制度?据丁香园"新型冠状病毒感染肺炎疫情实时动态"显示,...ChinaFood, Drugs, Healthcare, Life SciencesDeHeng Law Offices